[1]
Giorgi, S. et al. 2025. Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Aug. 2025), e2025061. DOI:https://doi.org/10.4084/MJHID.2025.061.